356 related articles for article (PubMed ID: 29987582)
1. Aging and Apolipoprotein E in HIV Infection.
Geffin R; McCarthy M
J Neurovirol; 2018 Oct; 24(5):529-548. PubMed ID: 29987582
[TBL] [Abstract][Full Text] [Related]
2. Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.
Cysique LA; Brew BJ
J Neurovirol; 2019 Oct; 25(5):710-721. PubMed ID: 30635846
[TBL] [Abstract][Full Text] [Related]
3. Current understanding of HIV-associated neurocognitive disorders pathogenesis.
Gannon P; Khan MZ; Kolson DL
Curr Opin Neurol; 2011 Jun; 24(3):275-83. PubMed ID: 21467932
[TBL] [Abstract][Full Text] [Related]
4. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
[TBL] [Abstract][Full Text] [Related]
5. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort.
Valcour V; Shikuma C; Shiramizu B; Watters M; Poff P; Selnes OA; Grove J; Liu Y; Abdul-Majid KB; Gartner S; Sacktor N
J Neuroimmunol; 2004 Dec; 157(1-2):197-202. PubMed ID: 15579298
[TBL] [Abstract][Full Text] [Related]
6. Aging, neurocognitive impairment and adherence to antiretroviral therapy in human immunodeficiency virus-infected individuals.
Pinheiro CA; Mattos Souza LD; Motta JV; Kelbert EF; Martins CS; Souza MS; Pinheiro KA; Coelho FM; Pinheiro RT
Braz J Infect Dis; 2016; 20(6):599-604. PubMed ID: 27789283
[TBL] [Abstract][Full Text] [Related]
7. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J; Tyor W
J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
[TBL] [Abstract][Full Text] [Related]
8. Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review.
Aung HL; Aghvinian M; Gouse H; Robbins RN; Brew BJ; Mao L; Cysique LA
AIDS Behav; 2021 Mar; 25(3):917-960. PubMed ID: 33025390
[TBL] [Abstract][Full Text] [Related]
9. Childhood trauma interacts with ApoE to influence neurocognitive function in women living with HIV.
Womersley JS; Spies G; Seedat S; Hemmings SMJ
J Neurovirol; 2019 Apr; 25(2):183-193. PubMed ID: 30478798
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities.
Joseph J; Colosi DA; Rao VR
Curr HIV Res; 2016; 14(5):389-399. PubMed ID: 27009096
[TBL] [Abstract][Full Text] [Related]
11. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
[TBL] [Abstract][Full Text] [Related]
12. Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.
Clark US; Cohen RA
Curr Opin Investig Drugs; 2010 Aug; 11(8):884-900. PubMed ID: 20721831
[TBL] [Abstract][Full Text] [Related]
13. Differential course of HIV-1 infection and APOE polymorphism.
Corder EH; Paganelli R; Giunta S; Franceschi C
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):E87. PubMed ID: 19004794
[No Abstract] [Full Text] [Related]
14. Cognitive changes in patient living with HIV-AIDS and apolipoprotein-E polymorphism: is there an association?
Brito-Marques PR; Rocha-Filho PAS; Dellalibera E; Muniz MTC; Cunha-Correia C
Mol Biol Rep; 2020 Nov; 47(11):8757-8762. PubMed ID: 33085049
[TBL] [Abstract][Full Text] [Related]
15. Accelerated and accentuated neurocognitive aging in HIV infection.
Sheppard DP; Iudicello JE; Morgan EE; Kamat R; Clark LR; Avci G; Bondi MW; Woods SP;
J Neurovirol; 2017 Jun; 23(3):492-500. PubMed ID: 28321696
[TBL] [Abstract][Full Text] [Related]
16. Dementia and neurocognitive disorders due to HIV-1 infection.
Ances BM; Ellis RJ
Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
[TBL] [Abstract][Full Text] [Related]
17. HIV-Associated Neurocognitive Disorder (HAND): Relative Risk Factors.
Kompella S; Al-Khateeb T; Riaz OA; Orimaye SO; Sodeke PO; Awujoola AO; Ikekwere J; Goodkin K
Curr Top Behav Neurosci; 2021; 50():401-426. PubMed ID: 32720161
[TBL] [Abstract][Full Text] [Related]
18. The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders.
Levine AJ; Singer EJ; Shapshak P
AIDS Behav; 2009 Feb; 13(1):118-32. PubMed ID: 18264751
[TBL] [Abstract][Full Text] [Related]
19. HIV-associated neurocognitive disorders (HAND).
Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
[TBL] [Abstract][Full Text] [Related]
20. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A
Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
